Date | Company Name | Action | Current Price | Price Target | Rating | Impact on Share Price |
---|
3/18/2024 | RGLS Regulus Therapeutics | Initiated Coverage | $2.00 | $6.00 | Outperform | Low |
3/18/2024 | MIRM Mirum Pharmaceuticals | Lower Price Target | $26.00 | $44.00 ➝ $43.00 | Outperform ➝ Outperform | Low |
3/18/2024 | WBA Walgreens Boots Alliance | Lower Price Target | $21.00 | $23.00 ➝ $22.00 | Market Perform ➝ Market Perform | Low |
3/14/2024 | SPRB Spruce Biosciences | Downgrade | $1.00 | $9.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
3/11/2024 | AMLX Amylyx Pharmaceuticals | Downgrade | $3.00 | | Outperform ➝ Market Perform | Low |
3/6/2024 | RGNX REGENXBIO | Upgrade | $22.00 | $37.00 | Market Perform ➝ Outperform | Low |
3/5/2024 | SPRY ARS Pharmaceuticals | Upgrade | $9.00 | $6.00 ➝ $18.00 | Market Perform ➝ Outperform | Low |
3/4/2024 | KYTX Kyverna Therapeutics | Initiated Coverage | $27.00 | $48.00 | Outperform | Low |
2/26/2024 | ACCD Accolade | Initiated Coverage | $10.00 | $16.00 | Outperform | Low |
2/26/2024 | ALGN Align Technology | Initiated Coverage | $316.00 | $310.00 | Market Perform | Low |
2/26/2024 | CAH Cardinal Health | Initiated Coverage | $110.00 | $125.00 | Outperform | Low |
2/26/2024 | COR Cencora | Initiated Coverage | $239.00 | $261.00 | Outperform | Low |
2/26/2024 | CERT Certara | Initiated Coverage | $18.00 | $19.00 | Market Perform | Low |
2/26/2024 | DOCS Doximity | Initiated Coverage | $28.00 | $32.00 | Market Perform | Low |
2/26/2024 | DGX Quest Diagnostics | Initiated Coverage | $128.00 | $135.00 | Market Perform | Low |
2/26/2024 | HSIC Henry Schein | Initiated Coverage | $74.00 | $78.00 | Market Perform | Low |
2/26/2024 | CVS CVS Health | Initiated Coverage | $78.00 | $88.00 | Outperform | Low |
2/26/2024 | TDOC Teladoc Health | Initiated Coverage | $15.00 | $17.00 | Market Perform | Low |
2/26/2024 | NVST Envista | Initiated Coverage | $21.00 | $19.00 | Underperform | Low |
2/26/2024 | GDRX GoodRx | Initiated Coverage | $7.00 | $8.00 | Outperform | Low |
2/26/2024 | HIMS Hims & Hers Health | Initiated Coverage | $16.00 | $10.00 | Market Perform | Low |
2/26/2024 | IQV IQVIA | Initiated Coverage | $254.00 | $290.00 | Outperform | Low |
2/26/2024 | LH Laboratory Co. of America | Initiated Coverage | $210.00 | $260.00 | Outperform | Low |
2/26/2024 | MCK McKesson | Initiated Coverage | $530.00 | $600.00 | Outperform | Low |
2/26/2024 | OMI Owens & Minor | Initiated Coverage | $25.00 | $24.00 | Market Perform | Low |
2/26/2024 | PDCO Patterson Companies | Initiated Coverage | $27.00 | $36.00 | Outperform | Low |
2/26/2024 | PINC Premier | Initiated Coverage | $22.00 | $22.50 | Market Perform | Low |
2/26/2024 | PGNY Progyny | Initiated Coverage | $36.00 | $49.00 | Outperform | Low |
2/26/2024 | RCM R1 RCM | Initiated Coverage | $13.00 | $14.00 | Outperform | Low |
2/26/2024 | XRAY DENTSPLY SIRONA | Initiated Coverage | $33.00 | $42.00 | Outperform | Low |
2/26/2024 | WBA Walgreens Boots Alliance | Initiated Coverage | $21.00 | $23.00 | Market Perform | Low |
2/22/2024 | APLT Applied Therapeutics | Initiated Coverage | $6.00 | $12.00 | Outperform | Low |
2/21/2024 | RAPT RAPT Therapeutics | Downgrade | $8.00 | $42.00 ➝ $10.00 | Outperform ➝ Market Perform | Low |
2/20/2024 | ENGN enGene | Initiated Coverage | $18.00 | $31.00 | Outperform | Low |
2/20/2024 | CBAY CymaBay Therapeutics | Reiterated Rating | $32.00 | $32.50 | Outperform ➝ Market Perform | Low |
2/20/2024 | BTSG BrightSpring Health Services | Initiated Coverage | $9.00 | $15.00 | Outperform | Low |
2/9/2024 | SYBX Synlogic | Reiterated Rating | $2.00 | | Outperform ➝ Market Perform | Low |
2/7/2024 | AMGN Amgen | Downgrade | $271.00 | $324.00 ➝ $318.00 | Outperform ➝ Market Perform | Low |
2/5/2024 | UTHR United Therapeutics | Initiated Coverage | $234.00 | $330.00 | Outperform | Low |
1/31/2024 | TSVT 2seventy bio | Upgrade | $4.00 | $5.00 ➝ $18.00 | Market Perform ➝ Outperform | Low |
1/30/2024 | NPCE NeuroPace | Initiated Coverage | $13.00 | $22.00 | Outperform | Low |
1/29/2024 | IMNM Immunome | Initiated Coverage | $22.00 | $30.00 | Outperform | Low |
1/23/2024 | PYXS Pyxis Oncology | Initiated Coverage | $5.00 | $12.00 | Outperform | Low |
1/12/2024 | AXNX Axonics | Reiterated Rating | $68.00 | $71.00 | Outperform ➝ Market Perform | Low |
1/8/2024 | AGL agilon health | Downgrade | $5.00 | | Outperform ➝ Market Perform | Low |
12/22/2023 | ALVR AlloVir | Downgrade | $1.00 | | Outperform ➝ Market Perform | Low |
12/19/2023 | WVE Wave Life Sciences | Upgrade | $6.00 | $5.00 ➝ $12.00 | Market Perform ➝ Outperform | Low |
12/15/2023 | RPHM Reneo Pharmaceuticals | Reiterated Rating | $2.00 | | Outperform ➝ Market Perform | Low |
12/13/2023 | INCY Incyte | Upgrade | $57.00 | $78.00 | Market Perform ➝ Outperform | Low |
12/8/2023 | NBTX Nanobiotix | Initiated Coverage | $6.00 | $11.00 | Outperform | Low |
11/30/2023 | TNYA Tenaya Therapeutics | Initiated Coverage | $5.00 | $7.00 | Outperform | Low |
11/28/2023 | LXEO Lexeo Therapeutics | Initiated Coverage | $16.00 | $19.00 | Outperform | Low |
11/14/2023 | ABVX ABIVAX Société Anonyme | Initiated Coverage | $14.00 | $20.00 | Outperform | Low |
11/7/2023 | ZNTL Zentalis Pharmaceuticals | Downgrade | $14.00 | $15.00 | Outperform ➝ Market Perform | Low |
10/30/2023 | TSVT 2seventy bio | Downgrade | $4.00 | $6.00 | Outperform ➝ Market Perform | Low |
10/20/2023 | BEAM Beam Therapeutics | Downgrade | $34.00 | $75.00 ➝ $20.00 | Outperform ➝ Market Perform | Low |
10/18/2023 | FDMT 4D Molecular Therapeutics | Upgrade | $31.00 | $24.00 | Market Perform ➝ Outperform | Low |
10/16/2023 | PODD Insulet | Initiated Coverage | $172.00 | $184.00 | Outperform | Low |
10/16/2023 | VCEL Vericel | Initiated Coverage | $44.00 | $42.00 | Outperform | Low |
10/16/2023 | ISRG Intuitive Surgical | Initiated Coverage | $393.00 | $342.00 | Outperform | Low |
10/16/2023 | TNDM Tandem Diabetes Care | Initiated Coverage | $31.00 | $21.00 | Market Perform | Low |
10/16/2023 | INSP Inspire Medical Systems | Initiated Coverage | $199.00 | $159.00 | Market Perform | Low |
10/16/2023 | SWAV Shockwave Medical | Initiated Coverage | $277.00 | $263.00 | Outperform | Low |
10/16/2023 | EW Edwards Lifesciences | Initiated Coverage | $93.00 | $75.00 | Market Perform | Low |
10/16/2023 | DXCM DexCom | Initiated Coverage | $135.00 | $110.00 | Outperform | Low |
10/16/2023 | PRCT PROCEPT BioRobotics | Initiated Coverage | $49.00 | $37.00 | Outperform | Low |
10/16/2023 | AXNX Axonics | Initiated Coverage | $68.00 | $70.00 | Outperform | Low |
10/16/2023 | AXGN AxoGen | Initiated Coverage | $8.00 | $9.00 | Outperform | Low |
10/11/2023 | AMGN Amgen | Upgrade | $271.00 | $267.00 ➝ $318.00 | Market Perform ➝ Outperform | Low |
10/6/2023 | NBIX Neurocrine Biosciences | Boost Price Target | $139.00 | $125.00 ➝ $135.00 | | Low |
9/29/2023 | GPCR Structure Therapeutics | Boost Price Target | $35.00 | $46.00 ➝ $97.00 | | Low |
9/21/2023 | SPRY ARS Pharmaceuticals | Downgrade | $9.00 | | Outperform ➝ Market Perform | Low |
9/18/2023 | PTCT PTC Therapeutics | Lower Price Target | $29.00 | $44.00 ➝ $30.00 | | Low |
9/8/2023 | SPRB Spruce Biosciences | Upgrade | $1.00 | $3.00 ➝ $9.00 | Market Perform ➝ Outperform | Low |
8/15/2023 | CYTK Cytokinetics | Initiated Coverage | $64.00 | $58.00 | Outperform | Low |
8/15/2023 | DSGN Design Therapeutics | Reiterated Rating | $3.00 | $6.00 | Outperform ➝ Market Perform | Low |
8/15/2023 | GLTO Galecto | Reiterated Rating | $1.00 | $13.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
8/8/2023 | NUVL Nuvalent | Initiated Coverage | $78.00 | $42.00 | Market Perform | Low |
8/8/2023 | IDYA IDEAYA Biosciences | Initiated Coverage | $43.00 | $33.00 | Outperform | Low |
8/8/2023 | EXEL Exelixis | Initiated Coverage | $23.00 | $18.00 | Market Perform | Low |
8/4/2023 | NVCR NovoCure | Initiated Coverage | $14.00 | $51.00 | Outperform | Low |
7/26/2023 | BLTE Belite Bio | Reiterated Rating | $41.00 | $25.00 | Outperform | Low |
7/24/2023 | NBIX Neurocrine Biosciences | Upgrade | $139.00 | | Market Perform ➝ Outperform | Low |
7/13/2023 | CYRX Cryoport | Downgrade | $15.00 | | Outperform ➝ Market Perform | Low |
7/10/2023 | BMY Bristol-Myers Squibb | Reiterated Rating | $52.00 | | Market Perform | Low |
6/20/2023 | EHAB Enhabit | Reiterated Rating | $11.00 | | Underperform | Low |
6/12/2023 | OCS Oculis | Reiterated Rating | $12.00 | | Outperform | Low |
6/5/2023 | BPMC Blueprint Medicines | Downgrade | $87.00 | | Market Perform ➝ Underperform | Low |
5/30/2023 | ELEV Elevation Oncology | Upgrade | $4.00 | | Market Perform ➝ Outperform | Low |
5/12/2023 | ARWR Arrowhead Pharmaceuticals | Downgrade | $28.00 | | Outperform ➝ Market Perform | Low |
5/12/2023 | BOLT Bolt Biotherapeutics | Upgrade | $1.00 | | Market Perform ➝ Outperform | Low |
5/1/2023 | DHR Danaher | Reiterated Rating | $251.00 | | Outperform | Low |
4/24/2023 | PRTA Prothena | Reiterated Rating | $25.00 | | Outperform | Low |
4/14/2023 | GNFT Genfit | Reiterated Rating | $4.00 | | Outperform | Low |
4/12/2023 | ARWR Arrowhead Pharmaceuticals | Upgrade | $28.00 | | Market Perform ➝ Outperform | Low |
4/12/2023 | CNTB Connect Biopharma | Reiterated Rating | $1.00 | | Outperform | Low |
4/11/2023 | CORT Corcept Therapeutics | Reiterated Rating | $24.00 | $25.00 | Market Perform | Low |
3/31/2023 | ABT Abbott Laboratories | Boost Price Target | $112.00 | $90.00 ➝ $102.00 | Market Perform | Low |
3/30/2023 | ACLX Arcellx | Boost Price Target | $69.00 | $35.00 ➝ $39.00 | Outperform | Low |
3/27/2023 | REGN Regeneron Pharmaceuticals | Upgrade | $960.00 | | Market Perform ➝ Outperform | Low |